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Abstract: The boron heterocyclic compound dipottasium trioxohydroxytetraflourotriborate, K2[B3O3F4OH] has been listed as a promising new 
therapeutic for the epidermal changes treatment. In order to elucidate its free radical scavenging activity, several appropriate thermodynamic 
molecular descriptors were calculated with the help of quantum-chemistry methods and their values were compared with the data obtained 
for ascorbic acid, trimethlyboroxine and trimethoxyboroxine. Considering the results, it may be suggested that the single electron transfer 
followed by proton transfer (SET-PT) is more favourable reaction pathway than hydrogen atom transfer (HAT) for the halogenated boroxine 
K2[B3O3F4OH]. Experimental support is provided by evaluating the in-vitro antioxidant activity of the investigated compounds in terms of their 
ferric-reducing antioxidant power (FRAP). Our study reveals that all three examined boroxines are extremely weak antioxidants. 
 





HE interest in boron-containing compounds has 
spurred over the last 20 years. Boron has an empty p-
orbital, which makes it highly reactive toward nucleophiles, 
in the attempt to attain a stable octet configuration. 
Particularly, boronic acids have been studied due to their 
low molecular masses, their thermal stability, low toxicity, 
mild acidity and inertness to water and oxygen.[1] They act 
as excellent reactants and exhibit strong bioactivity. 
Boronic acids form several derivates that remain relatively 
unexplored. Boroxines are boronic acid anhydrides, 
consisting of 6-membered, heterocyclic compounds 
composed of alternating oxygen and singly hydrogenated 
boron atoms.[2] Due to their unique electron configu-
rations, boroxines react readily with Lewis basis and are 
potentially selective enzyme inhibitors. They have the 
ability to bind to the active sites of enzymes and thus, 
prevent the catalytic reactions.[3] Previous in vivo and in 
vitro studies have reviled that boronic acids and their 
derivatives possess anticancer, antibacterial and antiviral 
properties.[4–6] It is known that modified dipeptidyl boronic 
acid is present as trimeric boroxine in a chemoterapeutic 
agent for treatment of multiple myeloma, bortezomib 
(Velacade®). 
 Recently, halogenated boroxine (dipotassium trioxo-
hydroxytetrafluorotriborate, K2[B3O3F4OH]) has attacked 
much attention as a promising novel therapeutic for pre-
vention and/or treatment of benign and malignant skin le-
sions.[7,8] Furthermore, this compound displays some 
interesting properties that open up the possibility of its ap-
plication in future conventional, medical, dermatological 
and cosmetic formulations. Halogenated boroxine 
K2[B3O3F4OH] is highly soluble in water, which could facili-
tate the production of pharmaceutical compositions. This 
solubility contributes to its high bioavailability, with effec-
tive absorption at the site of administration on the skin. 
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cytostatic effects of K2[B3O3F4OH]  on human lymphocyte 
cultures and antiproliferative effect on basal cell carcinoma 
culture.[9] A different group of authors analysed the in vivo 
genotoxic effects of K2[B3O3F4OH] on BALB/c mice – an 
inbred albino research mouse strain[10] – by applying retic-
ulocytes micronucleus assay.[11] Both of these studies have 
confirmed that exposure to K2[B3O3F4OH] in tested concen-
trations is not harmful to human or mammalian health. Few 
other studies addressed the impact of K2[B3O3F4OH] on 
inhibition of enzymes associated with hypothesized anti-
cancer properties.[12] It has been reported that halogenated 
boroxine K2[B3O3F4OH] inhibits catalase activity and human 
carbonic anhydrases.[13,14] Ivanković et al. have determined 
that K2[B3O3F4OH] has a strong in vitro and in vivo anti-
tumor activity, comparable to that of well-known anti-
cancer drug, 5-fluorouracil.[15] In addition, Pojskić et al. ob-
served that treatment with K2[B3O3F4OH] induces a 
significant decrease of cell viability in melanoma cell line at 
concentrations of 0.1 and 1 mM and causes deregulation of 
more than 30 genes known as common antitumor drug 
targets.[16]  
 This paper estimates the antioxidant activity of the 
halogen boroxine K2[B3O3F4OH] (DPTFTB). To the best of 
our knowledge, this is the first study dealing with radical-
scavenging potential of the specified compound. In the ab-
sence of knowledge about the action mechanism of 
K2[B3O3F4OH] as free radical scavenger, we have decided to 
study it using both theoretical and experimental approach. 
The theoretical framework comprises several descriptors 
estimated with the help of quantum-chemical calculations. 
The computed values are compared with the data obtained 
for the well-known antioxidant - namely, the ascorbic acid 
(ASCACD) - and the two relatively simple, commercially 
available boroxines, trimethylboroxine (TMHYLB) and tri-
methoxyboroxine (TMOXYB). Based on the results of com-
parison, we draw conclusions about the radical scavenging / 
antioxidant activity of the halogenated boroxine 
K2[B3O3F4OH] and relate them to the experimental results 





Antioxidants can deactivate free radicals through three 
main reaction mechanisms: direct hydrogen atom transfer 
(HAT), single electron transfer followed by proton transfer 
(SET-PT or ET-PT) and sequential proton loss electron 
transfer (SPLET).[17–19] 
 In the HAT mechanism, the hydrogen atom of OH 
group is transferred from antioxidant to active radical,  
which is neutralized, while the antioxidant itself becomes a 
radical: 
 
 • •⋅ ⋅ ⋅ → ⋅ ⋅ ⋅ +A OH A O H  (1) 
 
 The SET-PT mechanism is a two-step reaction. The 
first step is the electron transfer from antioxidant to active 
radical, resulting in the formation of a radical cation and an 
anion. The electron transfer is followed by a proton transfer 
from radical cation to anion, producing the corresponding 
neutral radical: 
 
 − + + •⋅ ⋅ ⋅ − → ⋅ ⋅ ⋅ − → ⋅ ⋅ ⋅A OH e A OH H A O  (2) 
 
 The probability of SET-PT mechanism depends on 
the antioxidant reduction capability, which cannot be 
unambiguously determined on purely chemical basis. 
 The SPLET mechanism occurs when the antioxidant 
anion is formed upon losing the proton from neutral 
moiety. The second step is an electron transfer from the 
resulting anion to the active radical, producing a neutral 
molecule and an antioxidant radical: 
 
 + − − •⋅ ⋅ ⋅ − → ⋅ ⋅ ⋅ − → ⋅ ⋅ ⋅A OH H A O e A O  (3) 
 
 The HAT and SPLET mechanism are only feasible 
when a dissociable hydrogen atom (or, respectively, a 
proton) is present. Note that all of the aforementioned 
mechanisms address only the formation of the stable 
radical intermediate, A–O• and do not account for its later 
fate that can involve any number of subsequent 
transformations. 
 The ideal chemical structures to scavenge free 
radicals combine the tendency to donate a hydrogen atom 
or an electron from the hydroxyl groups of the compound 
with the expanded ring system to delocalize an unpaired 
 
Figure 1. The main radical scavenging reaction mechanisms: 
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electron.[20] Based on its structure, as shown in Figure 2, it 
is obvious that K2[B3O3F4OH] meets both of these demands, 
which leads us to assume that it might have a strong 
antioxidant potential. The other two boroxines included in 
this study - trimethylboroxine and trimethoxyboroxine - do 
not possess a hydroxyl group and in their case, providing 
that they do act as antioxidants, the reaction mechanism is 
most likely carried out through formation of the unstable 
carbanion intermediate. The boron atoms in these 
compounds form three single, stable, covalent bonds with 
three valence electrons and as such are not expected to 
participate in the electron transfer. Halogenated boroxine 
K2[B3O3F4OH] molecule displays some unique behaviour 
due to the existence of 4 severely electronegative fluorine 
atoms bounded to the two boron atoms. To form these 
bonds, boron atoms presumably need to activate their 
valence electrons from the inner shell, close to the nucleus. 
This phenomenon affects the number and the 
delocalization of unpaired electrons over the entire 
molecule and results in the local bond configuration change 
from trigonal sp2 to tetrahedral sp3 hybridization. 
 Energy requirement computations for each 
mechanism may help us identify which radical scavenging 
mechanism, responsible for the antioxidant reaction, is 
preferable under certain conditions. The HAT mechanism is 
characterized by the homolytic bond dissociation enthalpy 
(BDE) of the OH group. A lower BDE values is usually 
attributed to a greater ability of the hydroxyl group to 
donate a hydrogen atom which indicates better antioxidant 
properties. BDE can be calculated using the following 
equation: 
 
 • •= ⋅ ⋅ ⋅ + − ⋅ ⋅ ⋅BDE (A O ) (H ) (A OH)H H H  (4) 
 
where H(A···O•) is the enthalpy of the radical, H(H•) is the 
enthalpy of the hydrogen atom and H(A···OH) is the 
enthalpy of the neutral compound. 
 Thermodynamical parameters that describe SET-PT 
mechanism are adiabatic ionisation potential (AIP) in the 
first step and proton dissociation enthalpy (PDE) in the 
second step. The molecules with low AIP and PDE values 
are more susceptible to ionization and have stronger 
antioxidant properties. These parameters can be computed 
as follows: 
 
 + −= ⋅ ⋅ ⋅ + − ⋅ ⋅ ⋅IP (A OH ) (e ) (A OH)H H H  (5) 
 
where H(A···OH+) is the enthalpy of the radical cation, H(e–) 
is the enthalpy of the electron and H(A···OH) is the enthalpy 
of the neutral compound. 
 
 • + += ⋅ ⋅ ⋅ + − ⋅ ⋅ ⋅PDE (A O ) (H ) (A OH )H H H  (6) 
 
where H(A···O•) is the enthalpy of the radical, H(H+) is the 
enthalpy of the proton and H(A···OH+) is the enthalpy of the 
radical cation. 
 Finally, proton affinity (PA) and electron transfer 
enthalpy (ETE) are quantitative descriptors related to SPLET 
mechanism: 
 
 − += ⋅ ⋅ ⋅ + − ⋅ ⋅ ⋅PA (A O ) (H ) (A OH)H H H  (7) 
 
where H(A···O–) is the enthalpy of the anion, H(H+) is the 
enthalpy of the proton and H(A···OH) is the enthalpy of the 
neutral compound. 
Table 1. Chemical and physical properties of the selected 
compounds. 
Property ASCACD TMHYLB tMOXYB DPTFTB 
Formula C6H8O6 C3H9B3O3 C3H9B3O6 K2[B3O3F4OH] 
Form powder liquid liquid powder 
Colour white colourless colourless white 
Molar mass / 
g mol–1 
176.12 125.53 173.50 251.60 
Density /  
g cm–3 1.694 0.898 1.195 unknown 
Melting  









available yes yes yes no 
 
 
     
 
 
     
Figure 2. Molecular structures of tested compounds: (a) 
ascorbic acid, (b) trimethlyboroxine, (c) trimethoxyboroxine, 
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 • − −= ⋅ ⋅ ⋅ + − ⋅ ⋅ ⋅ETE (A O ) (e ) (A O )H H H  (8) 
 
where H(A···O•) is the enthalpy of the radical, H(e–) is the 
enthalpy of the electron and H(A···O–) is the enthalpy of the 
anion. 
 Apart from these descriptors, the other informative 
quantities that are more closely associated with electron-
donor capabilities of the molecule are HOMO and LUMO 
energies. EHOMO is the energy of the highest occupied 
molecular orbital. It represents the initial energy required 
to release an electron from the compound. The compounds 
with higher HOMO energy values have better ability to 
donate an electron during interaction with free 
radicals.[21,22] In other words, the compound has a positive 
relation with the antioxidant activity. ELUMO is the ionization 
energy of the lowest unoccupied molecular orbital, i.e. the 
amount of energy launched when an electron is absorbed 
by a molecule. The energy difference between the HOMO 
and LUMO orbital determines the chemical reactivity of the 
molecule. The larger the gap between HOMO and LUMO 
orbital, the more kinetically stable and less chemically 
active antioxidant the compound is. 
 The theoretical values were obtained using the 
Spartan program package.[23] All the examined compounds 
were drawn and pre-optimized by applying the molecular 
mechanic method using MM+ force field.[24] The 
optimization of the geometry was adopted using the semi-
empiric method AM1 (Austin Model 1).[25] The options 
designated in the optimization process - such as total 
charge and multiplicity - were as follows: charge 0 and 
singlet for closed shell species, charge 0 and doublet for 
radical species, charge –1 and singlet for the anionic species 
and charge 1 and doublet for the cationic species.[26] Due to 
its unique structure, the K2[B3O3F4OH] geometry was 
optimized using a special set of parameter values: charge  
–2 and triplet for closed shell species, charge –2 and 
quartet for radical species, charge –3 and triplet for the 
anionic species and charge –1 and quartet for the cationic 
species. The ground-state equilibrium geometries were 
optimized at the restricted Hartree-Fock level of theory and 
the optimization of the corresponding radical anion and 
radical cation geometries was performed with unrestricted 
open shell Hartree-Fock level of theory.[27] For the species 
having more conformers, all conformers were investigated. 
The conformer with the lowest electronic energy was used 
in this work. 
Experimental Setup 
The in vitro antioxidant activity of the three examined 
boroxine compounds was evaluated in terms of their ferric-
reducing antioxidant power (FRAP), which were compared 
with a standard antioxidant. FRAP assay is a simple, quick 
and inexpensive test that is frequently used to measure 
total antioxidant capacity in the wide variety of biological 
samples and pure compounds. The principle is based on the 
reduction of ferric(III) tripyridytriazine (TPTZ) complex to 
ferrous form that can be monitored by measuring the 
change of absorption at 593 nm. The reaction is 
reproducible and linearly related to the molar concen-
tration of the electron-donating antioxidant present in the 
reaction mixture. 
 All commercially available chemicals and reagents 
were supplied by Sigma-Aldrich, Merck, Germany. The 
halogenated boroxine K2[B3O3F4OH] was synthesised in the 
Laboratory of Physical Chemistry, Department of 
Chemistry, Faculty of Science, University of Sarajevo, 
Bosnia and Hercegovina, through a simple reaction 
between potassium biflouride KHF2 and boric acid in the  
2 : 3 ratio, as reported in literature.[28] All the measurements 
were carried out on the Specord 200 Plus spectro-
photometer. 
 FRAP assay was performed according to the method 
of Benzie and Strain with slight modifications.[29] The stock 
solutions included 300 mM acetate buffer (3.1 g C2H3NaO2 
· 3H2O and 16 mL C2H4O2), pH 3.6, 10 mM TPTZ (2,4,6-
tripyridl-s-triazine) solution in 40 mM HCl and 20 mM FeCl3 
· 6H2O solution. The FRAP working solution was freshly 
prepared each time by mixing 25 mL acetate buffer, 2.5 mL 
TPTZ and 2.5 mL FeCl3 · 6H2O. 0.075 mL of sample solutions 
at different concentrations (0.1, 0.5, 1, 5 and 10 mM) were 
added to 2.25 mL of FRAP reagent and mixed well. Each 
concentration was measured in three replicates and the 
mean values were calculated. The absorbance readings 
were taken at 595 nm at t = 0 and after 30 minute 
incubation at 37 °C in darkness. Aqueous solutions of 
known Fe(II) concentration (FeSO4 · 7H2O) were utilized to 
generate a calibration curve using a similar procedure. The 
FRAP values were expressed as the concentration of the 
compound having a ferric-reducing ability equivalent to 
that of 1 mM of iron(II) sulphate and compared with 
ascorbic acid. FRAP working solution instead of a sample 
was used as a blank. 
 
RESULTS AND DISCUSSION 
Quantum Chemical Studies 
All the computed enthalpies for the four investigated 
compounds are presented in Table 2. In the calculations, 
the following vacuum enthalpy values of proton, electron 
and hydrogen atom were employed: H(H+) = 0.00236 Ha 
(i.e. Hartree), H(e–) = 0.20043 Ha and H(H•) = –0.49764 Ha. 
 The data in Table 2 reveals that BDE value of 
halogenated boroxine K2[B3O3F4OH] is lower than the 
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trimethoxyboroxine by 198.45 and 128.95 kJ mol–1, 
respectively. This can be explained by the fact that the C–H 
bonds present in trimethly- and trimetoxyboroxine are 
weaker than O–H bond in K2[B3O3F4OH]. Among the four 
examined compounds, ascorbic acid exhibited the lowest 
BDE value (304.3 kJ mol–1), indicating that the HAT 
mechanism is the most favourable in this molecule. 
Generally, our results have shown that the BDE values of 
the currently studied species increase in the order ASCACD 
< DPTFTB < TMOXYB < TMHYLB. 
 The IP values, characterising the first step in the SET-
PT mechanism, have been found to increase in the order 
DPTFTB < ASCACD < TMOXYB < TMHYLB. From this ranking, 
it can be concluded that halogenated boroxine 
K2[B3O3F4OH] exhibits the greatest electron transfer 
capability, while trimethylboroxine shows the least 
electron transferability. The trend in the PDE values of the 
compounds studied is opposite to that of the IP values. 
Note that the PDE values for ascorbic acid (–294.65 kJ mol–1), 
trimethlyboroxine (–415.75 kJ mol–1) and trimethoxyboroxine 
(–408.24 kJ mol–1) are all negative, which suggests that the 
proton transfer process of their cation radicals is 
exothermic. 
 The PA values, related to the SPLET mechanism, can 
be classified in the order ASCACD < TMHYLB < TMOXYB < 
DPTFTB. As a general observation, the PA values for the 
compounds studied are higher than their PDE values, which 
can be attributed to the high reactivity of the cationic 
radicals. The only exception to this trend is the ascorbic 
acid, which has roughly the same PA and PDE values. Table 
2 also shows that, apart from the halogenated boroxine 
K2[B3O3F4OH], the ETE values of the examined compounds 
are significantly lower than their corresponding IP values. 
 Thermodynamical favourableness of the particular 
antioxidant mechanism can be estimated on the basis of 
enthalpy values describing the first step of each 
mechanism. More specifically, the lowest enthalpy value 
indicates the most probable reaction pathway. To facilitate 
the comparisons, BDE, IP and PA values for all the 
compounds studied in this paper were plotted on the same 
axes, as illustrated in Figure 3. From this figure, it is evident 
that the preferred mechanism for the ascorbic acid, 
trimethly- and trimethoxyboroxine is the SPLET, since each 
of these compounds exhibits notably lower PA than the 
BDE and IP values. These results are in agreement with 
those reported in literature, confirming that SPLET is the 
predominant mechanism of antioxidant activity for 
ascorbic acid.[30] On the other hand, in case of the 
halogenated boroxine K2[B3O3F4OH], the most plausible 
mechanism of radical scavenging reaction is SET-PT, since 
its BDE, and particularly PA value, is considerably higher 
than IP, which undoubtedly rules out HAT and SPLET 
mechanisms. The second most favourable antioxidant 
mechanism for all the molecules studied is HAT. 
 The HOMO and LUMO energies are not antioxidant 
descriptors, but they can be connected to the antioxidant 
activity of the molecule. The molecular electron-donating 
ability is strictly correlated with the HOMO energy. Analysis 
of the computed HOMO orbital energy values in Table 3 
reveals that halogenated boroxine K2[B3O3F4OH] is 
characterized with the highest value of this parameter in 
vacuum. This result is highly compatible with the computed 
IP values and proves that K2[B3O3F4OH] has a higher ability 
to interact with free radicals and scavenge them via SET-PT 
mechanism. However, all three examined boroxine 
derivatives exhibit very large HOMO-LUMO gaps (9.33 eV, 
Table 2. Thermodynamical quantities relevant for anti-
oxidant mechanisms of selected compounds, all in kJ mol–1. 
Compound 
HAT SET-PT SPLET 
BDE IP PDE PA ETE 
ASCACD 304.30 924.33 –294.65 –213.44 762.61 
TMHYLB 697.85 1139.49 –415-75 89.13 741.34 
TMOXYB 628.35 1115.37 –408.24 116.75 731.22 
DPTFTB 499.40 308.75 –367.56 762.36 1474.31 
 Calculated enthalpies regard to the most stable conformation of the 
corresponding radical. 
Table 3. Energy levels (in eV) of the examined compounds. 
Compound EHOMO ELUMO ∆E 
ASCACD –10.54 –5.48 5.06 
TMHYLB –10.09 –0.76 9.33 
TMOXYB –9.58 5.39 14.97 




Figure 3. Superposition of BDE, IP and PA values for ascorbic 
acid, trimethlyboroxine, trimethoxyboroxine and halogen-
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14.97 eV and 10.45 eV, respectively). According to this 
descriptor, all of these compounds show far less chemical 
activity against free radical scavenging than ascorbic acid. 
Ferric-Reducing Antioxidant Power 
Assay 
The FRAP assay was employed to estimate the reducing 
ability of the selected compounds in vitro. In this test, the 
results revealed that a good linearity of ferrous sulphate 
(FeSO4) was obtained within the range of 0.15–1 mM (R2 = 
0.9971). The regression equation expressing the absorbance 
of ferrous sulphate standard solution as a function of 
concentration is: 
 
 0.4493 0.0773y x= +  (9) 
 
 Linearity of FRAP (dose-response curve) for FeSO4 
standard solution is shown in Figure 4. The respective FRAP 
assay values, calculated from the standard calibration curve 
using [Eq. (9)], are reported in Table 4. 
 As it can be seen, three boroxines studied exhibit 
negligible antioxidant activity, since their FRAP values are 
few orders of a magnitude lower than FRAP value for 
ascorbic acid and iron(II) sulphate. Among the three, 
trimethlyboroxine is showing the highest antioxidant 
power (0.113 %), while trimethoxyboroxine and halogen-
ated boroxine K2[B3O3F4OH] are having considerably lesser 
extent of free radical scavenging power (0.0277 and 0.068 %, 
respectively). One-way analysis of variance (ANOVA), 
followed by Tukey test, at α = 0.05 level of significance, 
confirms that there are statistically significant differences 
between antioxidant powers of the three boroxine 
compounds studied. 
 These results are in accordance with the findings of 
a previous study, conducted using DPPH methodology, 
which revealed that trimethyl- and trimethoxyboroxine do 
not scavenge free radicals via electron donation. The same 
study reported similar results for halogenated boroxine 
K2[B3O3F4OH], providing that at lower concentrations it 
exhibited slight antioxidant activity (from 0.38 to 0.92 %); 




Radical scavenging potential is based on the capability of a 
neutral molecule to generate stable radicals. Quantum-
chemical study based on the AM1 / Hartree-Fock method 
has been performed herein in order to determine the 
antioxidant activity of three different boroxine derivatives 
- halogenated boroxine K2[B3O3F4OH], trimethylboroxine 
and trimethoxyboroxine. The usual molecular descriptors 
BDE, IP, PDE, PA and ETE were used to assess 
thermodynamical favourableness of forming radicals via 
certain reaction pathway. Analysis of their values reveals 
that SPLET is the preferred mechanism of radical 
scavenging activity for trimethyl- and trimethoxyboroxine. 
However, in case of the halogenated boroxine 
K2[B3O3F4OH], the low IP values - considerably lower than 
BDE and PA values - indicate that the interaction of this 
compound with active radical most likely follows the SET-




ASCACD 201.5646 16.5117 
TMHYLB 0.1130 0.0041 
TMOXYB 0.0277 0.0007 
DPTFTB 0.0680 0.0024 
 
 
Figure 4. Ferrous sulphate (FeSO4) standard curve]. 
 
 
Figure 5. A comparison of selected boroxine compounds 
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PT mechanism. The BDE values for all three investigated 
boroxines have been found to be mutually very similar, 
which shows that all of these compounds have similar 
ability to react via the HAT mechanism. 
 On the other hand, large HOMO-LUMO gap values 
speak in favour of distinctly low chemical reactiveness of 
examined compounds. It should be pointed out that these 
results are in strong agreement with the corresponding 
experimental FRAP values, which clearly predict that these 
compounds are inactive antioxidants. Furthermore, the 
FRAP values of all three boroxine derivatives studied are 
few orders of a magnitude smaller than those for ascorbic 
acid. 
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